HomeBussinessWicklow-based Trinity Biotech could see shares delisted from Nasdaq

Wicklow-based Trinity Biotech could see shares delisted from Nasdaq


Related stories

Through Irish Eyes on road to Flemington Cup 2024

There is no doubting the staying credentials of Through...

Eoin McElholm heading to Australia for AFL trial

Up-and-coming Tyrone star Eoin McElholm has headed back to...

Notre Dame Fighting Irish Unveil Updated Home Football Jerseys

Although they leaked in the very first screenshot of...

US YouTube star tries Gaelic football at Co Fermanagh GAA club

An American YouTube star has captured the attention of...

Life sciences firm is currently listed on the Nasdaq Global Select Market

The Trinity Biotech facility in Bray

Trinity Biotech, a life-sciences company, has been warned by Nasdaq that it could be delisted after failing to comply with market value rules.

According to a filing it made with the US Securities and Exchange Commission, Trinity Biotech said it had received a determination letter from Nasdaq stating the exchange could delist its American depositary shares (ADSs) from the Nasdaq Global Select Market.

Trinity received a deficiency letter that gave it 180 days to regain compliance

Nasdaq made the determination based on Trinity’s non-compliance with the minimum market value of publicly held shares (MVPHS).

Companies must maintain a minimum MVPHS of $15m to remain listed on the Nasdaq Global Select Market. A failure to meet the minimum MVPHS requirement occurs if the deficiency continues for 30 consecutive business days.

In November 2023, Trinity received a deficiency letter that gave it 180 days to regain compliance.

In response to Nasdaq’s more recent letter, Trinity requested a hearing before a Nasdaq panel. The move stayed any suspension or delisting action pending the hearing.

The panel can grant Trinity an extension to November 18, 2024, to regain compliance.

Trinity said the notification was expected due to the proportion of traded equity that qualifies under Nasdaq rules as part of its public float. It said a significant proportion of its equity is held by a small number of large position investors. These holdings do not qualify as public float under Nasdaq rules.

Trinity was engaging with Nasdaq, adding the process was confidential.

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories